Z Master
Overview
Explore the profile of Z Master including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Master Z, Fu W, Paciulli D, Sipp D
Clin Pharmacol Ther
. 2017 Jul;
102(2):177-179.
PMID: 28695633
The direct-to-consumer marketing of unproven stem cell interventions (SCIs) is a serious public health concern. Regulations and education have had modest impact, indicating that different actors must play a role...
2.
Murthy V, Mallik S, Master Z, Sharma P, Mahantshetty U, Shrivastava S
Technol Cancer Res Treat
. 2011 Mar;
10(2):179-85.
PMID: 21381796
The study was designed to compare Helical Tomotherapy (HT) based IMRT and conventional sliding window (SW IMRT) in patients with high risk prostate cancer. Complementary plans with HT and SWIMRT...
3.
Gupta T, Mallik S, Master Z, Phurailatpam R, Laskar S
Clin Oncol (R Coll Radiol)
. 2010 Oct;
23(2):86-94.
PMID: 20884186
Aims: Diffuse and extensive involvement of the scalp/skull by malignancy mandates holo-cranial radiotherapy with the aim to deliver homogeneous doses to the planning target volume (PTV) while minimising the dose...
4.
Sharma D, Gupta T, Jalali R, Master Z, Phurailatpam R, Sarin R
Br J Radiol
. 2009 Jul;
82(984):1000-9.
PMID: 19581313
This study aimed to establish the feasibility of intensity-modulated radiation therapy (IMRT) in craniospinal irradiation (CSI) using conventional linear accelerator (IMRT_LA) and compare it dosimetrically with helical TomoTherapy (IMRT_Tomo) and...
5.
Gupta T, Basu A, Master Z, Jalali R, Munshi A, Sarin R
Technol Cancer Res Treat
. 2009 Jan;
8(1):15-22.
PMID: 19166238
Lung cancer is the commonest source of brain metastases, which has been traditionally treated with Whole Brain Radiation Therapy (WBRT) with or without focal boost. We herein report our preliminary...
6.
Kinhikar R, Master Z, Deshpande D
Australas Phys Eng Sci Med
. 2008 Aug;
31(2):139-45.
PMID: 18697705
Two-dimensional (2D) treatment verifications were performed for fifty patients planned and treated with helical tomotherapy (HT). The treatment verification consisted of an extended dose range (EDR2) film measurement as well...
7.
Master Z, Jones N, Tran J, Jones J, Kerbel R, Dumont D
EMBO J
. 2001 Nov;
20(21):5919-28.
PMID: 11689432
Tek/Tie-2 is an endothelial cell (EC)-specific receptor tyrosine kinase that plays a critical role in angiogenesis via its regulation by the angiopoietin family of growth factor ligands. Angiopoietin-1 (Ang1) can...
8.
Jones N, Voskas D, Master Z, Sarao R, Jones J, Dumont D
EMBO Rep
. 2001 May;
2(5):438-45.
PMID: 11375937
Disruption of the signaling pathways mediated by the receptor tyrosine kinase Tek/Tie2 has shown that this receptor plays a pivotal role in vascularization of the developing embryo. In this report,...
9.
Maisonpierre P, Jones N, Campbell A, Master Z, Bendeck M, Alitalo K, et al.
Cardiovasc Res
. 2001 Feb;
49(3):659-70.
PMID: 11166279
The endothelial cell (EC) specific tyrosine kinase receptor, Tie2, interacts with at least two ligands, angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2). Ang1 stimulates Tie2 receptor autophosphorylation, while Ang2 has been reported...
10.
Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, et al.
J Biol Chem
. 1999 Oct;
274(43):30896-905.
PMID: 10521483
The Tek/Tie2 receptor tyrosine kinase plays a pivotal role in vascular and hematopoietic development. To study the signal transduction pathways that are mediated by this receptor, we have used the...